TCG Crossover Management, LLC

Q3 2026 13F-HR Holdings

Location
Palo Alto, CA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
57
Total value ($000)
$3,539,842
Net value change ($000)
-620,684 (-14.9%)
New positions
8
Sold out positions
5
Turnover %
13.9%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
KORSANA BIOSCIENCES INC 145,587 NEW
ADARX PHARMACEUTICALS INC 82,082 NEW
KOD 80,719 143.3%
AMLX 69,556 62.0%
ZLAB 47,459 40.7%
FIRST TRACKS BIOTHERAPEUTICS 44,356 76.1%
ENTXW 35,662 NEW
TARS 30,514 NEW
OBSIDIAN THERAPEUTICS INC 30,153 NEW
XNCR 11,817 29.9%
Top Reduces (Value $000, Stocks/ETFs)
ABVX -437,890 -54.7%
TNGX -114,891 -40.5%
COGT -107,817 -57.4%
GLUE -66,742 -59.7%
RVMD -63,844 -100.0%
SRZN -38,227 -100.0%
ALT -30,400 -100.0%
MIRM -28,685 -23.1%
DYN -28,152 -27.5%
TYRA -27,752 -26.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type